The pharmaceutical industry’s ongoing demand to shorten drug development times, thus making significant cost savings, is driving technological advances forward at the same time as …

The clinical development path is rife with complexity that can stall or stop a drug’s journey to market. Paul Evans, Jeetendra Rao and Abigaile Betteridge …

The current concept of clinical trial conduct is a balance between benefits from treatment (efficacy) and risks that this treatment may have (risk). Maxim Kosov, …

Primary bone sarcomas are cancers of mesenchymal, non-epithelial derivation, originating from bone cells or their precursors. Kelechi K. Olu MD, MSc, Vijayanand Rajendran and Mohamed …

The biopharmaceutical industry invests billions of dollars annually into clinical research to address a range of debilitating respiratory conditions. Phil Lake at ERT discusses how …

There are currently a number of pharmaceutical or device-based heart failure therapies in clinical use, with numerous promising candidates under development. Bobby Stutz and Dr …

Facioscapulohumeral MD, likely the most prevalent form of MD, currently has no cure, but several factors point to the potential for successful development of a …

The UAE has rapidly transformed its healthcare sector in the past decade. Adhiti Sharad Kumar explains the UAE’s 2021 Vision, which states that the UAE …

Innovator companies have employed a variety of multipronged strategies to counter biosimilar competition. These include development of ‘biobetter’, gaining regulatory approval for additional indications and …

Although James Lind conducted the first controlled clinical trial back in 1747, it wasn’t until the Nuremberg Code in 1947 and the Declaration of Helsinki …